Literature DB >> 28496020

Predictors of Long-Term Mortality in Patients With Acute Heart Failure.

Mengchao Jin1, Siqi Wei1, Rongrong Gao1, Kai Wang1, Xuejuan Xu1, Wenming Yao1, Haifeng Zhang1, Yanli Zhou1, Dongjie Xu1, Fang Zhou1, Xinli Li1.   

Abstract

To investigate parameters which were related with long-term mortality in patients hospitalized for acute heart failure (AHF).A total of 287 patients with AHF presenting to the First Affiliated Hospital of Nanjing Medical University were enrolled into the registry from April 2012 to January 2015. The primary endpoint was all-cause mortality within 1 year; the association between variables and prognosis was assessed after 1 year.Among the 287 patients, 17 did not continue follow-up and 47 (17.4%) passed away. Baseline NT-proBNP and sST2 concentrations were higher amongst deceased than among survivors (P < 0.001). Serum sodium concentrations of patients who died were lower (P < 0.001). In receiver operator characteristics (ROC) analyses, the area under the curve (AUC) values for NT-proBNP, sST2, and serum sodium to predict 1-year mortality were 0.699 (95%CI 0.639-0.755), 0.692, (95%CI 0.634-0.747), and 0.694 (95%CI 0.634-0.750), respectively. The optimal cut-off points for NT-proBNP, sST2, and serum sodium were 2137.0 ng/L, 35.711 ng/mL, and 136.6 mmol/L, respectively. In Cox regression analysis, ln-transformed NT-proBNP (HR 1.546, P = 0.039), ln-transformed sST2 (HR1.542, P = 0.049), and serum sodium (HR 0.880, P = 0.000) values reliably predicted long-term mortality after multivariable adjustment.In patients with acute heart failure, NT-proBNP, sST2 and serum sodium are potential predictors of 1-year mortality.

Entities:  

Keywords:  N-terminal pro-brain natriuretic peptide; Prognosis; Sodium; Soluble ST2

Mesh:

Substances:

Year:  2017        PMID: 28496020     DOI: 10.1536/ihj.16-219

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  5 in total

1.  Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies.

Authors:  Yingxian Liu; Ligang Fang; Wei Chen; Yanlin Zhu; Xue Lin; Yining Wang; Xiao Li; Qian Wang; Zhenyu Liu
Journal:  Cardiovasc Diagn Ther       Date:  2020-06

Review 2.  Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis.

Authors:  Christina Ip; King Sum Luk; Vincent Lok Cheung Yuen; Lorraine Chiang; Ching Ki Chan; Kevin Ho; Mengqi Gong; Teddy Tai Loy Lee; Keith Sai Kit Leung; Leonardo Roever; George Bazoukis; Konstantinos Lampropoulos; Ka Hou Christien Li; Gary Tse; Tong Liu
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-18

3.  Prognostic value of soluble ST2 postaortic valve replacement: a meta-analysis.

Authors:  Gary Tse; Christina Ip; King Sum Luk; Mengqi Gong; Yan Yee Ting; Ishan Lakhani; George Bazoukis; Guangping Li; Konstantinos P Letsas; Mei Dong; Tong Liu; Martin C S Wong
Journal:  Heart Asia       Date:  2018-03-06

4.  Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials.

Authors:  Jin-Dong Zhao; Jing-Jing Jia; Ping-Shuan Dong; Di Zhao; Xu-Ming Yang; Dao-Lin Li; Hui-Feng Zhang
Journal:  BMJ Open       Date:  2018-08-30       Impact factor: 2.692

5.  Evaluating risk prediction models for adults with heart failure: A systematic literature review.

Authors:  Gian Luca Di Tanna; Heidi Wirtz; Karen L Burrows; Gary Globe
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.